Newsletters

The European Medicines Agency (EMA) publishes newsletters to provide updates on various topics to patients, healthcare professionals and the pharmaceutical industry.

Human medicines highlights, published monthly, contains key information on human medicines and changes to regulatory processes in the past month. These highlights do not cover all the Agency's activities in the area of human medicines.

EMA provides an RSS feed of the human medicines highlights. To subscribe, use the below link and follow our user guide on how to subscribe to RSS feeds:

• Human Medicines Highlights newsletter

The newsletter for micro-, small- and medium-sized enterprises (SMEs), published four times a year, provides key updates to SMEs on the European regulatory environment.

For older editions, see the Newsletter archive.

What's new in pharmacovigilance, also published four times a year, updates qualified persons for pharmacovigilance on guidance, regulations and events.

The Clinical Trials Information System (CTIS) newsletter, published twice a year, provides key updates on the CTIS evolvement. To subscribe, use the following email ct.communication@ema.europa.eu.